Have you read these stories?

View: Bio data of a wonder bio fuel

CBG is derived from agri-waste and other forms of organic waste — a hi-tech version of gobar gas. Unlike the latter, though, a CBG pla ...
The Economic Times
English EditionEnglish Editionहिन्दी
| 25 January, 2021, 02:14 AM IST | E-Paper

    U.S. GOLD

    Gold prices today slip as traders book profits

    Globally, Gold prices eased on Wednesday as encouraging vaccine developments pushed investors towards riskier equities, although hopes for more U.S. stimulus kept bullion near the two-week highs hit in the previous session.

    Gold prices today rise bucking trend in international market

    Globally, Gold prices edged lower on Thursday as news of the world's first vacci...

    Gold jumps 2% on dollar slide, stimulus bets

    Spot gold climbed 1.8% to $1,809.01 per ounce by 10:34 a.m. EST (1534 GMT). U.S. gold futures ga...

    • Globally, gold edged up on Tuesday, as investors weighed optimism over prospects for a Covid-19 vaccine against a surge in infections and possible restrictive measures to combat the pandemic that risk derailing a swift global economic recovery.

      ​​​Spot gold rose 0.1 per cent to $1,778.76 per ounce by 0049 GMT, while U.S. gold futures were little changed at $1,780.50.​

      Spot gold dipped 1% to $1,770.56 per ounce by 1337 GMT, and was down 5.7% so far this month. The metal also hit its lowest level since July 2 at $1,764.29 earlier in the session.

      "A break below $1,800 an ounce could well see further losses towards $1,760 as positive sentiment around a possible vaccine continues to weigh on demand for the traditional safe haven asset," said Michael Hewson, chief market analyst at CMC Markets UK.

      In the spot market, gold prices rose marginally by Rs 17 to Rs 48,257 per 10 gram in the national capital on Thursday, according to HDFC Securities. Silver prices also gained Rs 28 to Rs 59,513 per kilogram.

      The dollar index held close to near three-month lows, raising gold's appeal for other currency holders. Meanwhile, an extension of coronavirus restrictions in Germany and a weak growth forecast for Britain kept European shares flat.

      Globally, gold prices ticked up on Thursday as disappointing US jobs data and a resurgence of COVID-19 cases worldwide cast doubts over a swift economic recovery and paused a rally in traditional risk assets.

      ​​Spot gold had fallen 0.4% to $1,863.21 per ounce by 1328 GMT and U.S. gold futures were 0.6% lower at $1,861.40. Britain's AstraZeneca said its vaccine could be around 90% effective and will have as many as 200 million doses by the end of 2020.

      In the spot market, gold prices on Friday inched up by Rs 65 to Rs 49,551 per 10 grams in the national capital reflecting gains in the international rates, according to HDFC Securities. Silver prices also jumped Rs 298 to Rs 61,232 per kg.

      Spot gold fell 0.8% to $1,856.58 per ounce by 9:47 a.m. EST (1447 GMT), after hitting its lowest since Nov. 9 at $1,851.83. U.S. gold futures slipped 0.9% to $1,856.80.

      Gold futures were down 0.39 per cent at Rs 50,570 per 10 grams. Gold prices are off recent highs of Rs 56,379. Silver futures for December delivery were trading 0.55 per cent lower at Rs 62,902 per kg.

      ​​Spot gold rose 0.1% to $1,880.81 per ounce by 0707 GMT, while U.S. gold futures were down 0.4% at $1,878.30. Gold shed as much as 1.3% on Monday after Moderna said its vaccine was 94.5% effective in a late-stage trial.

    Load More...
    The Economic Times